IP Library Granted Patent US 10,098,821
Granted Patent B2
US 10,098,821 · App. 15/525,455 · Granted Oct 16, 2018

Process of manufacture of an antiperspirant composition

Inventors: Kevin Ronald Franklin (Wirral, GB); Anestis Kastrinakis (Leeds, GB); Craig James Luckwell (Leeds, GB); Philip Christopher Waterfield (Heswall, GB)
Assignee: Conopco, Inc.
A61K8/26A61K8/062A61K8/20A61K8/34A61K8/44A61Q15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,098,821
App. No.
15/525,455
Granted
Oct 16, 2018
Kind
B2
Abstract

A process for manufacture of an antiperspirant composition comprising the reaction of an aqueous solution of aluminum sesquichlorohydrate, water soluble calcium salt and amino acid, at a total anhydrous solids content of from 33 to 60% by weight and at a temperature of at least 65° C., for a period of from 1 to 24 hours, wherein the molar ratio of water soluble calcium salt to aluminum sesquichlorohydrate is at least 1:40 and the molar ratio of amino acid to aluminum sesquichlorohydrate is at least 1:20, the mixture then being cooled to less than 25° C. and diluted with at least an equal weight of water or to a total anhydrous solids content of less than 31% by weight, the dilution phase being performed within 10 days of cooling phase.

Claims (17)

1. A process for manufacture of an antiperspirant composition comprising the reaction of an aqueous solution of aluminium sesquichlorohydrate, water soluble calcium salt and amino acid, at a total anhydrous solids content of from 33 to 60% by weight and at a temperature of at least 65° C., for a period of from 1 to 24 hours, wherein the molar ratio of water soluble calcium salt to aluminium sesquichlorohydrate is at least 1:40 and the molar ratio of amino acid to aluminium sesquichlorohydrate is at least 1:20, the mixture then being subjected to a cooling phase in which it is cooled to less than 25° C. and a dilution phase in which it is diluted to a total anhydrous solids content of less than 25% by weight, the dilution phase being performed within 10 days of cooling phase.

2. The process according to claim 1 , wherein the aluminium sesquichlorohydrate is of formula Al 2 (OH) 4.4 Cl 1.6 to Al 2 (OH) 4.9 Cl 1.1 .

3. The process according to claim 1 , wherein the molar ratio of water soluble calcium salt to aluminium sesquichlorohydrate is at least 1:20 and the molar ratio of amino acid to aluminium sesquichlorohydrate is at least 1:10.

4. The process according to claim 1 , the reaction of the aqueous solution of aluminium sesquichlorohydrate, water soluble calcium salt and amino acid is continued until a Band III content of at least 40% is achieved.

5. The process according to claim 1 , wherein in the cooling phase the mixture is cooled to less than 25° C. at a rate of at least 0.9° C. per minute.

6. The process according to claim 1 , wherein the mixture is still at a temperature of at least 65° C. when the dilution phase is commenced.

7. The process according to claim 6 , wherein the temperature of the water used for the dilution is no greater than 20° C. less than the temperature of the mixture to which it is added.

8. The process according to claim 7 , wherein the temperature of the water used for the dilution is no greater than 10° C. less than the temperature of the mixture to which it is added.

9. The process according to claim 1 , wherein the dilution phase is performed within 5 days of the cooling phase.

10. The process according to claim 1 , wherein the activation process is performed at an anhydrous solids level of at least 40% by weight.

11. The process according to claim 1 , wherein the dilution is carried out within 7 days of the cooling phase.

12. An aqueous antiperspirant composition prepared according to claim 1 .

13. An aqueous antiperspirant composition prepared according to claim 10 .

14. A cosmetic method of attaining an antiperspirancy benefit comprising the topical application of a composition according to claim 11 the surface of the human body.

15. The process according to claim 1 wherein the aluminium sesquichlorohydrate is of formula Al 2 (OH) 4.7 Cl 1.3 to Al 2 (OH) 4.9 Cl 1.1 .

16. The process according to claim 1 wherein the reaction of the aqueous solution of aluminium sesquichlorohydrate, water soluble calcium salt and amino acid is continued until a Band III content of at least 50% is achieved.

17. The process according to claim 1 wherein the reaction of the aqueous solution of aluminium sesquichlorohydrate, water soluble calcium salt and amino acid is continued until a Band III content of at least 60% is achieved.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2017
From: FRANKLIN, KEVIN RONALD; KASTRINAKIS, ANESTIS; LUCKWELL, CRAIG JAMES; WATERFIELD, PHILIP CHRISTOPHER
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 042339/0439 →
Priority Claims (1)
EP 14193902 · Nov 19, 2014 · regional
Continuity (1)
Related Publication 20170333307A1 · Nov 23, 2017